scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00134-006-0246-Y |
P698 | PubMed publication ID | 16788803 |
P50 | author | Karl Werdan | Q29918327 |
Ursula Müller-Werdan | Q87347446 | ||
P2093 | author name string | Hendrik Schmidt | |
Michael Buerke | |||
Martin Russ | |||
Alexander Keller | |||
Ralf Hennen | |||
P2860 | cites work | Impaired chemoreflex sensitivity in adult patients with multiple organ dysfunction syndrome--the potential role of disease severity | Q30320530 |
The inflammatory reflex | Q34165907 | ||
The effect of statins on mortality in patients with bacteremia | Q34374856 | ||
Statins: a preventive strike against sepsis in patients with cardiovascular disease? | Q43472421 | ||
Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin | Q44179197 | ||
Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis | Q44277349 | ||
HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis | Q44880979 | ||
Simvastatin blunts endotoxin-induced tissue factor in vivo. | Q46433020 | ||
Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups | Q46691588 | ||
Should treatment of sepsis include statins? | Q55040785 | ||
Statin therapy prior to ICU admission: protection against infection or a severity marker? | Q64135581 | ||
Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use | Q78355502 | ||
Prior statin therapy is associated with a decreased rate of severe sepsis | Q80408206 | ||
Statins: the next step in adjuvant therapy for sepsis? | Q81470477 | ||
Statin therapy is associated with fewer deaths in patients with bacteraemia | Q81470480 | ||
P433 | issue | 8 | |
P921 | main subject | statin therapy | Q62562875 |
P304 | page(s) | 1248-1251 | |
P577 | publication date | 2006-06-21 | |
P1433 | published in | Intensive Care Medicine | Q15749164 |
P1476 | title | Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome | |
P478 | volume | 32 |
Q30400569 | A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial |
Q37287361 | Chronic Statin Use and Long-Term Rates of Sepsis: A Population-Based Cohort Study |
Q58995173 | Continuation or Discontinuation of Statin Therapy Did Not Influence Patient Outcomes after the Development of Acute Respiratory Distress Syndrome |
Q42284839 | Critical role for integrin-β4 in the attenuation of murine acute lung injury by simvastatin. |
Q28542607 | Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions |
Q55615824 | Differential Effects of Statins on Inflammatory Interleukin-8 and Antimicrobial Peptide Human Β-Defensin 2 Responses in Salmonella-Infected Intestinal Epithelial Cells. |
Q36681810 | Effect of early statin treatment in patients with cardiogenic shock complicating acute myocardial infarction |
Q30318280 | Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study |
Q37960531 | Immune-modulating interventions in critically ill septic patients: pharmacological options |
Q30319125 | Impaired regulation of cardiac function in sepsis, SIRS, and MODS. |
Q58584684 | Improved survival with continuation of statins in bacteremic patients |
Q26801464 | Interactions between Autophagy and Bacterial Toxins: Targets for Therapy? |
Q37203857 | Is There Potential for Repurposing Statins as Novel Antimicrobials? |
Q38056781 | Lovastatin for adult patients with dengue: protocol for a randomised controlled trial |
Q36497872 | Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial |
Q33919029 | Preadmission statin use and one-year mortality among patients in intensive care - a cohort study |
Q40055455 | Prehospital HMG Co-A reductase inhibitor use and reduced mortality in hemorrhagic shock due to trauma |
Q44463455 | Reduction in mortality associated with statin therapy in patients with severe sepsis |
Q90059548 | Repositioned Drugs for Inflammatory Diseases such as Sepsis, Asthma, and Atopic Dermatitis |
Q33769398 | Retracted: Atorvastatin Improves Survival in Septic Rats: Effect on Tissue Inflammatory Pathway and on Insulin Signaling |
Q37596136 | Role of claudin-5 in the attenuation of murine acute lung injury by simvastatin |
Q34153309 | Simvastatin attenuates ventilator-induced lung injury in mice |
Q34285683 | Simvastatin increases the in vivo activity of the first-line tuberculosis regimen |
Q44432695 | Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation. |
Q33587600 | Statin treatment and mortality in bacterial infections--a systematic review and meta-analysis |
Q44975687 | Statin use and rupture of abdominal aortic aneurysm |
Q36797719 | Statins and sepsis: multiple modifications at multiple levels. |
Q44356684 | Statins and the risk of pneumonia: a population-based, nested case-control study |
Q35567062 | Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study |
Q33595333 | Statins in candidemia: clinical outcomes from a matched cohort study |
Q37867264 | Statins in sepsis |
Q36369699 | Statins in the critically ill |
Q41585009 | Streptococcal m1 protein triggers farnesyltransferase-dependent formation of CXC chemokines in alveolar macrophages and neutrophil infiltration of the lungs |
Q34531972 | Systematic review and meta-analysis on the association between outpatient statins use and infectious disease-related mortality |
Q36566297 | The association of prior statin use in septic shock treated with early goal directed therapy. |
Q36772248 | The role of statin therapy in sepsis. |
Search more.